Orvacabtagene autoleucel
orvacabtagene autoleucel
JCARH125 CONSISTS OF HUMAN CULTURE EXPANDED GENETICALLY MODIFIED AUTOLOGOUS T CELLS FOR CELL-BASED GENE THERAPY. CD4+ CD8+ T CELLS ARE DERIVED FROM ISOLATED BLOOD OF THE PATIENT AND ARE TRANSDUCED WITH NON-REPLICATIVE SELF-INACTIVATING (SIN) LENTIVIRAL V
jcarh125 consists of human culture expanded genetically modified autologous t cells for cell-based gene therapy. cd4+ cd8+ t cells are derived from isolated blood of the patient and are transduced with non-replicative self-inactivating (sin) lentiviral v